A lack of representative enrollment can weaken the impact of a clinical trial and skew findings. How can researchers improve the representation of participants included in a clinical trial? The Duke-Margolis Center for Health Policy explores the answer to this...
Please read Dr. Barrett’s article in the Journal of Allergy and Clinical Immunology titled, “Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth.”...
The majority of individuals with multiple sclerosis (MS) treat the chronic and progressive neurological disorder with oral medications, likely because of many factors, including convenience, consumer advertising and approval by health insurers, according to Rutgers...
A Rutgers-led consortium has been awarded $18 million to help tobacco regulators by providing the U.S. Food and Drug Administration (FDA) with real-time data on tobacco and nicotine marketing, products and consumer behaviors. “Nothing like this has ever been attempted...
The widely-available drug fentanyl, already the number one killer of Americans under 50, could be weaponized and used for terroristic mass poisoning, according to health experts at Rutgers and other institutions. “Before fentanyl, the only viable mass poisons were...
